The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting. Since its founding in 1988, AMCP boasts a membership of greater than 8000, comprised of pharmacists, physicians, nurses, mid-level providers, and other medical practitioners.
Nearly 2500 managed care pharmacy professionals gathered in Florida for the AMCP Nexus 2018 at the Orlando World Center Marriott. This year’s theme was “Preparing for the Next Generation of Care.” The conference features more than 30 educational sessions and many ancillary programs on the trends and emerging models affecting the practice of managed care pharmacy.
Increased Health Resource Utilization Linked With Severe Adverse Events in Urothelial Cancer
Severe adverse events occurring during first-line therapy for metastatic urothelial cancer can result in significant burden to patients, families, and health care systems.
BTK Inhibitor vs Chemoimmunotherapy in Front-Line Leukemia OCM Episodes
Single-agent ibrutinib is associated with fewer monthly days with outpatient or ER visits as well as monthly health care cost savings for patients with CLL during a front-line OCM episode.
Economic Burden for Commercially-Insured Patients With Metastatic Pancreatic Cancer
Outpatient per-patient per-month costs are a significant driver of economic burden in patients receiving treatment for metastatic pancreatic cancer.
Budget Impact of Cellular Therapy Introduction for Relapsed, Refractory DLBCL
Adding tisagenlecleucel to the formulary for the treatment of adults with relapsed or refractory DLBCL after 2 or more prior lines of therapy had an incremental impact on the total budget from a US payer perspective.
